Chris Degnan - Chief Financial Officer at Galera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
GRTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Chris Degnan since 7/7/2023

Holdings reported by Chris Degnan for Galera Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 10,000 $22.5 K $2.25 Mar 13, 2023 Direct
Stock Option (Right to Buy) 185,000 Feb 25, 2023 Direct Common Stock

Transactions reported by Chris Degnan for Galera Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership